FEATURED ACTIVITIES

Brought to you by PleXus Communications and Rush University Medical Center

Updates from the National Multiple Myeloma Rounds Series

Faculty
Agne Paner, MD
Assistant Professor of Medicine at Rush University Medical Center,
Division of Hematology/Oncology and Stem Cell Transplant
Director, Coleman Foundation Comprehensive Multiple Myeloma Clinic
Rush University Medical Center
Chicago, IL


Updates from the National Multiple Myeloma Rounds Series: Focus on Relapsed Multiple Myeloma

Specialty: Oncology
Accreditation: 0.25 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Updates from the National Multiple Myeloma Rounds Series: Focus on Amyloidosis

Specialty: Oncology
Accreditation: 0.25 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Updates from the National Multiple Myeloma Rounds Series: Focus on Smoldering Multiple Myeloma

Specialty: Oncology
Accreditation: 0.25 CME/CNE/CPE
Accredited Provider: Rush University Medical Center


Realizing Improved Outcomes in Advanced Prostate Cancer through Evolving Research and Emerging Treatment Paradigms: Challenges and Opportunities

Faculty
Daniel P. Petrylak, MD
Professor of Medicine and Urology
Director, Genitourinary DART
Co-director, Signal Transduction Program
Smilow Cancer Center
Yale University School of Medicine
New Haven, CT


Realizing Improved Outcomes in Advanced Prostate Cancer through Evolving Research and Emerging Treatment Paradigms: Challenges and Opportunities - Part 1

Specialties: Oncology & Urology
Accreditation: 0.5 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Realizing Improved Outcomes in Advanced Prostate Cancer through Evolving Research and Emerging Treatment Paradigms: Challenges and Opportunities - Part 2

Specialties: Oncology & Urology
Accreditation: 0.5 CME/CNE/CPE
Accredited Provider: Rush University Medical Center


Evolving Treatment Paradigms in Advanced Prostate Cancer: Individualizing Treatment Strategies Based on Advancing Clinical Data

Faculty
Matthew B. Rettig, MD
Medical Oncologist
Ronald Reagan UCLA Medical Center and VA Greater Los Angeles Healthcare System
Los Angeles, CA


Evolving Treatment Paradigms in Advanced Prostate Cancer: Individualizing Treatment Strategies Based on Advancing Clinical Data—Part One

Specialties: Oncology & Urology
Accreditation: 0.5 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Evolving Treatment Paradigms in Advanced Prostate Cancer: Individualizing Treatment Strategies Based on Advancing Clinical Data—Part Two

Specialties: Oncology & Urology
Accreditation: 0.5 CME/CNE/CPE
Accredited Provider: Rush University Medical Center

Expert Perspectives on Improving Treatment of Patients with B-cell Non Hodgkin Lymphomas

Faculty
Thomas E. Witzig, MD
Professor of Medicine Mayo Clinic College of Medicine
Co-PI, University of Iowa/Mayo Clinic Lymphoma SPORE
Deputy Director of Clinical Research, Mayo Clinic Cancer Center
Rochester, MN


Specialties: Oncology & Hematology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Expert Perspectives in the Management of Chronic Lymphocytic Leukemia: Integrating Current and Emerging Agents/Regimens to Develop Evidence Based Clinical Management Strategies

Faculty
Jonathon B. Cohen, MD, MS
Department of Hematology and Medical Oncology
Emory University
Winship Cancer Institute
Atlanta, GA


Specialties: Oncology & Hematology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Advancing Treatment Options in the Management of Head and Neck Cancers

Faculty
Mark Klein, MD
Assistant Professor of Medicine
University of Minnesota
Minneapolis, MN


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Evolving Approaches for the Management of Waldenström’s Macroglobulinemia

Faculty
Edward Libby, MD
Fred Hutchinson Cancer Institute
Associate Professor, University of Washington
Seattle, WA


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Incorporating Best Practices and Advancing Therapeutic Options in the Treatment of Multiple Myeloma

Faculty
Andrew Branagan, MD
Mass General Hospital
Boston, MA


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Understanding the Disease Continuum and Navigating the Evolving Treatment Paradigms in Prostate Cancer

Faculty
William Oh, MD
Mount Sinai Hospital
New York, NY


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Evolving Strategies for Using CDK 4/6 Inhibitors in the Treatment of HR+ (HER2-) Advanced Breast Cancer

Faculty
Rita Nanda, MD
Associate Professor of Medicine
Director, Breast Oncology Program
University of Chicago
Chicago, IL


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Expert Guidance on the Latest Developments, Treatment Strategies, and Emerging Clinical Data in the Management of Multiple Myeloma

Faculty
Carol Ann Huff, MD
Associate Professor of Oncology
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, MD


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Current Trends in Multiple Myeloma: Customizing Treatment Strategies and Optimizing Outcomes

Faculty
Joshua Richter, MD
Mount Sinai Hospital
New York, NY


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Emerging Strategies for the Management of Chronic Lymphocytic Leukemia

Faculty
Joao Ascensao, MD
Washington DC Veterans Affairs Medical Center
Washington, DC


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Advancing Strategies in Prostate Cancer: Individualizing Treatment Plans Based on the Rapidly Evolving Landscape and Disease Continuum

Faculty
Julie Graff, MD
Associate Professor Medicine
Oregon Health & Science University
Portland, OR 


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Advances in High-Risk and Relapsed/Refractory Acute Myeloid Leukemia

Faculty
Mark Levis, MD, PhD
Director, Adult Leukemia Service
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University
Baltimore, Maryland 


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Navigating the Prostate Cancer Disease Continuum - Evolving Strategies in the Management of HSPC and CRPC

Faculty
Robert Dreicer, MD, MS, MACP, FASCO
Sectional Head Medical Oncology
Deputy Director, University of Virginia Cancer Center
Professor of Medicine and Urology
University of Virginia School of Medicine
Charlottesville, VA


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Optimizing Treatment of B-Cell Non-Hodgkin Lymphomas in the Modern Era

Faculty
Jonathon B. Cohen, MD, MS
Co-Director Lymphoma Program
Winship Cancer Institute
Emory University
Atlanta, GA


Part A

Specialty: Oncology
Accreditation: 0.5 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Part B

Specialty: Oncology
Accreditation: 0.5 CME/CNE/CPE
Accredited Provider: Rush University Medical Center


The Expanding Treatment Landscape of Waldenström’s Macroglobulinemia

Faculty
Steven P. Treon, MD, PhD
Director, Bing Center for Waldenström's Macroglobulinemia
Professor of Medicine, Harvard Medical School
Dana-Farber Cancer Institute
Boston, MA 


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Integrating New Treatment Options for B-Cell Non-Hodgkin Lymphomas into Practice

Faculty
Ian Flinn, MD
Director of Lymphoma Research Program
Sarah Cannon Research Institute
Tennessee Oncology/OneOncology
Nashville, TN


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Expert Perspectives on Navigating the Complex Treatment Landscape of Advanced Prostate Cancer

Faculty
Ulka Vaishampayan, MD
Chair, Phase I Therapeutics
Rogel Cancer Center
Professor of Medicine
University of Michigan
Ann Arbor, MI


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Navigating the Continuum of Care for Advanced Prostate Cancer (mHSPC, CRPC)

Faculty
Robert Dreicer, MD, MS, MACP, FASCO
Head, Medical Oncology Section
Associate Director for Clinical Research and Deputy Director
University of Virginia Cancer Center
Co-Director Mellon Urologic Institute
Professor of Medicine and Urology
University of Virginia School of Medicine
Charlottesville, Virginia


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Clinical Strategies to Optimize Outcomes Across the Disease Spectrum in Multiple Myeloma

Faculty
Jeffrey V. Matous, MD
Medical Director, Colorado Blood Cancer Institute
Clinical Professor of Medicine
University of Colorado Health Sciences Center
Denver, CO


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Expert Perspectives on Treating High-Risk and Relapsed/Refractory Acute Myeloid Leukemia

Faculty
Eytan M. Stein, MD
Director, Program for Drug Development in Leukemia
Assistant Professor
Leukemia Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, NY


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Evolving Standards of Care in Advanced Prostate Cancer: Incorporating the Latest Therapeutic Strategies

Faculty
Elizabeth Henry, MD
Associate Professor
Fellowship Program Director, Hematology/Oncology
Quality Medical Director, Hematology/Oncology
Loyola University Medical Center
Maywood, IL


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Precision Medicine to Improve Lung Cancer Outcomes: Recent Therapeutic Advances and Emerging Agents

Faculty
Millie Das, MD
Clinical Associate Professor, Stanford University
Chief, Oncology, VA Palo Alto Health Care System
Palo Alto, CA


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Optimizing Outcomes in Head & Neck Cancer with Immunotherapeutic Strategies

Faculty
Mark Klein, MD
Staff Physician, Minneapolis VA Health Care System
Assistant Professor of Medicine, University of Minnesota
Minneapolis, MN


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Advances in CAR T-Cell Therapies: Optimizing Outcomes and Implementation in Hematologic Malignancies

Faculty
Caron Jacobson, MD
Assistant Professor
Division of Medical Oncology
Department of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Expanding Treatment Options for Advanced Hepatocellular Carcinoma: Understanding the Evolving Role of Systemic Therapies

Faculty
Ghasson K. Abou-Alfa, MD
Medical Oncologist
Memorial Sloan Kettering Cancer Center
New York, NY


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Improving Survival for Veterans with Bladder Cancer – Translating New Knowledge into Clinical Practice

Faculty
Matthew D. Galsky, MD, FASCO
Professor of Medicine
Acting Chief, Division of Hematology and Medical Oncology
Icahn School of Medicine at Mount Sinai
Associate Director of Translational Research
Tisch Cancer Institute
New York, NY


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Optimizing the Care of Mantle Cell Lymphoma: Translating the Latest Advances into Clinical Practice

Faculty
Jonathon B. Cohen, MD, MS
Associate Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine
Co-Director, Lymphoma Program
Winship Cancer Institute of Emory University
Medical Director, Infusion Services
Winship Cancer Institute of Emory University
Atlanta, Georgia


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Optimizing Outcomes in Non-Small Cell Lung Cancer: Advances in the Management of EGFR-Mutated Disease

Faculty
Stephen V. Liu, MD
Associate Professor of Medicine,
Director of Thoracic Oncology and Director of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center
Washington, DC


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



© Copyright 2021